Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: Interaction with nitric oxide system

Annals of Plastic Surgery

Volumn 59, Issue 4, 2007, Pages 435-440

  Ghazinezami, Behtash ^a,b   Rahimpour, Sina ^a,b   Gholipour, Taha ^a,b   Ghasemi, Mehdi ^b   Sadeghipour, Hamed ^b   Mehr, Shahram Ejtemaie ^a,b   Emami Razavi, Seyed Hassan ^a,c   Dehpour, Ahmad Reza ^a,b,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cyclosporine; FK 506; Ischemic; Nitric oxide; Pharmacologic preconditioning; Random pattern skin flap; Tacrolimus

Indexed keywords

ARGININE; CYCLOSPORIN A; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; TACROLIMUS;

ANIMAL EXPERIMENT; ARTICLE; CLAMP; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; GRAFT SURVIVAL; ISCHEMIA; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; MALE; NONHUMAN; PEDICLED SKIN FLAP; POSTOPERATIVE CARE; PRIORITY JOURNAL; RAT; SKIN FLAP;

ANIMALS; CYCLOSPORINE; DRUG SYNERGISM; IMMUNOSUPPRESSIVE AGENTS; ISCHEMIC PRECONDITIONING; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; TACROLIMUS; TISSUE SURVIVAL;

EID: 34848820941     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000258982.86308.f0     Document Type: Article

References (43)

1. Kerrigan CL. Skin flap failure: pathophysiology. Plast Reconstr Surg. 1983;72:766-777.
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
3. Kiumehr S, Demehri S, Rabbani S, et al. Preconditioning of the rat random-pattern skin flap: modulation by opioids. Br J Plast Surg. 2005;58:58-64.
4. Matsumura H, Yoshizawa N, Vedder NB, et al. Preconditioning of the distal portion of a rat random-pattern skin flap. Br J Plast Surg. 2001;54:58-61.
5. Maldonado C, Stadelmann WK, Ramirez S, et al. Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid A. Plast Reconstr Surg. 2003;111:267-274.
6. Hosnuter M, Babuccu O, Kargi E, et al. Dual preconditioning effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg. 2003;50:398-402.
7. Vanrenterghem Y. Tacrolimus (FK 506) in kidney transplantation. Transplant Proc. 1998;30:2171-2173.
8. McMaster P, Buist L. FK 506 in transplantation. Transplant Proc. 1993;25:2684-2685.
9. Morris PJ. Cyclosporine, FK-506 and other drugs in organ transplantation. Curr Opin Immunol. 1991;3:748-751.
10. Singh D, Chander V, Chopra K. Cyclosporine protects against ischemia/ reperfusion injury in rat kidneys. Toxicology. 2005;207:339-347.
11. Krishnadasan B, Naidu B, Rosengart M, et al. Decreased lung ischemiareperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg. 2002;123:756-767.
12. Cetinkale O, Bilgic L, Ayan F, et al. Neutrophil-mediated injury in ischemic skin flaps: amelioration of ischemic injury by cyclosporine in the rat. Ann Plast Surg. 1996;37:66-74.
13. Hemenway CS, Heitman J. Calcineurin: structure, function, and inhibition. Cell Biochem Biophys. 1999;30:115-151.
14. Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie. 2002;84:153-166.
15. Hausenloy D, Wynne A, Duchen M, et al. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation. 2004;109:1714-1717.
16. Um SC, Suzuki S, Toyokuni S, et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg. 1998;101:785-792.
17. Zhang F, Oswald T, Holt J, et al. Regulation of inducible nitric oxide synthase in ischemic preconditioning of muscle flap in a rat model. Ann Plast Surg. 2004;52:609-613.
18. de Lessio C, Assuncao Silva F, Gloria MA, et al. Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells. Kidney Int. 2005;68:2508-2516.
19. Trajkovic V. Modulation of inducible nitric oxide synthase activation by immunosuppressive drugs. Curr Drug Metab. 2001;2:315-329.
20. Diaz-Ruiz A, Vergara P, Perez-Severiano F, et al. Cyclosporin-A inhibits inducible nitric oxide synthase activity and expression after spinal cord injury in rats. Neurosci Lett. 2004;357:49-52.
21. Diaz-Ruiz A, Vergara P, Perez-Severiano F, et al. Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats. Neurochem Res. 2005;30:245-251.
22. Beheshtian A, Demehri S, Kiumehr S, et al. ATP-sensitive potassium channels mediate the anti-ischemic properties of ischemic and pharmacologic preconditioning in rat random-pattern skin flap. Ann Plast Surg. 2006;57:94-99.
23. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, et al. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc. 1993;25:3303-3304.
24. Islam CF, Mathie RT, Dinneen MD, et al. Ischemia-reperfusion injury in rat kidney: the effect of preconditioning. Br J Urol. 1997;79:842-847.
25. Kume M, Yamamoto Y, Saad S, et al. Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med. 1996;128:251-258.
26. Wang BH, Ye C, Stagg CA, et al. Improved free musculocutaneous flap survival with induction of heat shock protein. Plast Reconstr Surg. 1998;101:776-784.
27. Pang CY, Neligan P, Zhong A, et al. Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. Am J Physiol. 1997;273:887-895.
28. Peralta C, Hotter G, Closa D, et al. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology. 1997;25:934-937.
29. Guo Y, Bao W, Wu WJ, et al. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol. 2000;95:479-484.
30. Yoshida H, Kusama Y, Kodani E, et al. Pharmacological preconditioning with bradykinin affords myocardial protection through NO-dependent mechanisms. Int Heart J. 2005;46:877-887.
31. Nandagopal K, Dawson TM, Dawson VL. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther. 2001;297:474-478.
32. Xi L, Jarrett NC, Hess ML, et al. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation. 1999;99:2157-2163.
33. Steenbergen C, Perlman ME, London RE, et al. Mechanism of preconditioning: ionic alterations. Circ Res. 1993;72:112-125.
34. + channels in ischemic preconditioning of skeletal muscle against infarction. Am J Physiol. 1997;273(1 pt 2):H44-51.
35. Takano H, Tang XL, Bolli R. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol. 2000;279:H2350-2359.
36. McDonald WS, Lo TP, Thurmond M, et al. Role of nitric oxide in skin flap delay. Plast Reconstr Surg. 2004;113:927-931.
37. Kuntscher MV, Juran S, Altmann J, et al. Role of nitric oxide in the mechanism of preclamping and remote ischemic preconditioning of adipocutaneous flaps in a rat model. J Reconstr Microsurg. 2003;19:55-60.
38. Kuntscher MV, Kastell T, Altmann J, et al. Acute remote ischemic preconditioning, II: the role of nitric oxide. Microsurgery. 2002;22:227-231.
39. Kim JS, Ohshima S, Pediaditakis P, et al. Nitric oxide: a signaling molecule against mitochondrial permeability transition- and pH-dependent cell death after reperfusion. Free Radic Biol Med. 2004;37:1943-1950.
40. Piantadosi CA, Tatro LG, Whorton AR. Nitric oxide and differential effects of ATP on mitochondrial permeability transition. Nitric Oxide. 2002;6:45-60.
41. Brookes PS, Salinas EP, Darley-Usmar K, et al. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem. 2000;275:20474-20479.
42. Sharov VG, Todor AV, Imai M, et al. Inhibition of mitochondrial permeability transition pores by cyclosporine a improves cytochrome C oxidase function and increases rate of ATP synthesis in failing cardiomyocytes. Heart Fail Rev. 2005;10:305-310.
43. Mathes SJ, Hansen SL. Flap classification and applications. In: Mathes SJ, ed. Plastic Surgery. Saunders; 2006:365-483.